Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 4 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 1 |
| Parenteral Nutrition Market to 2018 - Introduction | 9 | 1 |
| Parenteral Nutrition Market to 2018 - Overview | 10 | 5 |
| Clinical Nutrition | 10 | 1 |
| Enteral Nutrition | 11 | 1 |
| Parenteral Nutrition | 11 | 2 |
| A.S.P.E.N. Practice Guidelines for PN | 13 | 2 |
| Parenteral Nutrition Market to 2018 - Market Characterization and Forecasts | 15 | 4 |
| Revenue Forecasts | 15 | 1 |
| Parenteral Nutrition Market Drivers | 16 | 1 |
| Increase in the Incidence of Diseases such as Cancer, AIDS and GI Disorders that Require Nutrition Support | 17 | 1 |
| Increase in the Elderly Population will Drive PN Market Growth | 17 | 1 |
| The Home Parenteral Nutrition Sector will Witness Strong Market Growth | 17 | 1 |
| Parenteral Nutrition Market Restraints | 17 | 1 |
| Reimbursement Regulations will Hinder Market Growth in the US | 17 | 1 |
| Increasing Preference for Enteral Nutrition will Restrain Market Growth | 17 | 1 |
| Increasing Preference for Multi-chamber Bags Decreases Cost of Therapy | 18 | 1 |
| Parenteral Nutrition Market to 2018 - Geographical Landscape | 19 | 8 |
| Revenues by Geographical Segmentation | 19 | 2 |
| The US | 21 | 1 |
| Sales Value | 21 | 1 |
| Nutrient Market Segmentation | 22 | 1 |
| Key Products | 22 | 1 |
| Top Five Countries in Europe | 23 | 1 |
| Sales Value | 23 | 1 |
| Nutrient Market Segmentation | 24 | 1 |
| Key Products | 24 | 1 |
| Japan | 25 | 1 |
| Sales Value | 25 | 1 |
| Nutrient Market Segmentation | 26 | 1 |
| Key Products | 26 | 1 |
| Parenteral Nutrition Market to 2018 - Nutrient Market Segmentation | 27 | 5 |
| Overview | 27 | 1 |
| Amino Acids Market | 28 | 1 |
| Global Sales Value | 28 | 1 |
| Sales Value by Geography | 28 | 1 |
| Lipids Market | 29 | 1 |
| Global Sales Value | 29 | 1 |
| Sales Value by Geography | 29 | 1 |
| Carbohydrates Market | 30 | 1 |
| Global Sales Value | 30 | 1 |
| Sales Value by Geography | 30 | 1 |
| Additives Market | 31 | 1 |
| Global Sales Value | 31 | 1 |
| Sales Value by Geography | 31 | 1 |
| Parenteral Nutrition Market - Marketed Products | 32 | 19 |
| Baxter International Inc. | 32 | 1 |
| OLIMEL | 32 | 1 |
| Clinimix | 33 | 1 |
| ClinOleic 20% | 34 | 1 |
| Clinisol 15% | 35 | 1 |
| B. Braun Melsungen AG | 36 | 1 |
| NuTRIflex System | 36 | 1 |
| Lipofundin | 37 | 1 |
| Aminoplasmal | 38 | 1 |
| FreAmine III | 39 | 1 |
| Fresenius Kabi AG | 40 | 1 |
| Intralipid | 40 | 1 |
| SmofKabiven | 41 | 1 |
| Dipeptiven | 42 | 1 |
| Omegaven | 43 | 1 |
| Hospira, Inc. | 44 | 1 |
| Aminosyn | 44 | 2 |
| Liposyn | 46 | 1 |
| Otsuka Pharmaceutical Factory Inc. | 47 | 1 |
| Elneopa | 47 | 1 |
| Neoparen | 47 | 1 |
| B-Fluid | 48 | 1 |
| Terumo Corporation | 49 | 1 |
| Unicaliq | 49 | 1 |
| Fulcaliq | 50 | 1 |
| Parenteral Nutrition Market to 2018 - Competitive Landscape | 51 | 11 |
| Market Share Analysis: Parenteral Nutrition | 51 | 1 |
| Competitive Profiling | 52 | 1 |
| Baxter International Inc. | 52 | 1 |
| The Medication Delivery Division | 53 | 1 |
| SWOT Analysis | 53 | 1 |
| B. Braun Melsungen AG | 54 | 1 |
| The Hospital Care Division | 54 | 1 |
| SWOT Analysis | 55 | 1 |
| Fresenius Kabi AG | 56 | 1 |
| Clinical Nutrition Division | 56 | 1 |
| SWOT Analysis | 57 | 1 |
| Hospira, Inc. | 58 | 1 |
| SWOT Analysis | 59 | 1 |
| Otsuka Pharmaceutical Factory Inc. | 60 | 1 |
| Terumo Corporation | 61 | 1 |
| Parenteral Nutrition Market to 2018 - Strategic Consolidations | 62 | 5 |
| Overview | 62 | 1 |
| Major Acquisitions in the Parenteral Nutrition Market | 63 | 1 |
| Baxter International Completes Acquisition of Prism Pharma for $338m in April 2011 | 63 | 1 |
| Baxter Acquires Willow Healthcare Services in July 2009 | 63 | 1 |
| Fresenius Acquires Novartis Nutrition and Nestle Espana in December 2007 | 63 | 1 |
| Fresenius Kabi Acquires Infusia A.S. in December 2004 | 63 | 1 |
| Fresenius Kabi Acquires Clinico GmbH in October 2005 | 63 | 1 |
| Fresenius Kabi Acquires Isotec Nutrition from Alliance Pharmaceuticals in May 2004 | 63 | 1 |
| Hospira Acquires Clayton Manufacturing Facility from Fresenius Kabi in June 2004 | 63 | 1 |
| Major Agreements in the Parenteral Nutrition Market | 64 | 1 |
| Baxter Signs Agreement with Hanmi Pharmaceuticals in December 2010 | 64 | 1 |
| Hospira Signs a Five-year Agreement with Novation in October 2010 | 64 | 1 |
| B. Braun Signs Agreement with Amerinet Inc in October 2009 | 64 | 1 |
| B. Braun Signs Agreement with Premier Purchasing Partners in August 2008 | 64 | 1 |
| Hospira Announces New Contract with Premier Purchasing Partners in August 2008 | 65 | 1 |
| Hospira Announces New Contract with HealthTrust Purchasing Group in February 2008 | 65 | 1 |
| Baxter and Novation Sign Two-year Contract Extension in October 2007 | 65 | 1 |
| Baxter Announces Plans to Form Parenteral Nutrition Joint Venture with Baiyunshan in China in August 2007 | 65 | 1 |
| B. Braun Signs Agreement with Curlin Medical in March 2006 | 65 | 1 |
| Fresenius Kabi and Pharmatel Pty Ltd. Formed a Joint Venture in September 2004 | 66 | 1 |
| Parenteral Nutrition Market to 2018 - Appendix | 67 | 4 |
| Market Definitions | 67 | 1 |
| Abbreviations | 67 | 1 |
| Bibliography | 68 | 1 |
| Research Methodology | 69 | 2 |
| Coverage | 69 | 1 |
| Secondary Research | 69 | 1 |
| Primary Research | 69 | 1 |
| Section Methodology | 70 | 1 |
| Expert Panel Validation | 70 | 1 |
| Contact Us | 70 | 1 |
| Disclaimer | 70 | 1 |